Read + Share
Amedeo Smart
Independent Medical Education
Ball S, Jain AG, Aguirre LE, Al Ali N, et al. Hypomethylating Agent and Venetoclax in Patients with Chronic Myelomonocytic Leukemia: Is the Combination Indeed Better? Am J Hematol 2022 Feb 18. doi: 10.1002/ajh.26504.PMID: 35179241
Email
LinkedIn
Facebook
Twitter
Privacy Policy